Over the last four months, oil prices plunged by almost 50%, thanks to oversupply, trade war fears, and a stronger dollar. They have since recovered slightly, and according to Goldman Sachs, an OPEC “shock and awe” campaign could force prices higher, near-term. “Core-OPEC producers are adopting a shock and awe strategy, and exceeding their cut…

Small-Cap Pharmaceutical Stock Surges 246% on Positive Data

Never ignore a stock just because it appears to be down-and-out. You may just miss a triple-digit profit opportunity. Axsome Therapeutics (AXSM) is a great example. Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system (CNS) disorders. The Company’s product candidates include AXS-05, which is in Phase…